These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 34740764)

  • 1. Mechanisms of immune response to inorganic nanoparticles and their degradation products.
    Mohammapdour R; Ghandehari H
    Adv Drug Deliv Rev; 2022 Jan; 180():114022. PubMed ID: 34740764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applications.
    Mohammadpour R; Dobrovolskaia MA; Cheney DL; Greish KF; Ghandehari H
    Adv Drug Deliv Rev; 2019 Apr; 144():112-132. PubMed ID: 31295521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane interactions and antimicrobial effects of inorganic nanoparticles.
    Malekkhaiat Häffner S; Malmsten M
    Adv Colloid Interface Sci; 2017 Oct; 248():105-128. PubMed ID: 28807368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current understanding of interactions between nanoparticles and the immune system.
    Dobrovolskaia MA; Shurin M; Shvedova AA
    Toxicol Appl Pharmacol; 2016 May; 299():78-89. PubMed ID: 26739622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porous Inorganic Drug Delivery Systems-a Review.
    Sayed E; Haj-Ahmad R; Ruparelia K; Arshad MS; Chang MW; Ahmad Z
    AAPS PharmSciTech; 2017 Jul; 18(5):1507-1525. PubMed ID: 28247293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organic/inorganic nanohybrids as multifunctional gene delivery systems.
    Guo K; Zhao X; Dai X; Zhao N; Xu FJ
    J Gene Med; 2019 May; 21(5):e3084. PubMed ID: 30850992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.
    Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inorganic nanoparticles for cancer imaging and therapy.
    Huang HC; Barua S; Sharma G; Dey SK; Rege K
    J Control Release; 2011 Nov; 155(3):344-57. PubMed ID: 21723891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vacuolization of macrophages induced by large amounts of inorganic nanoparticle uptake to enhance the immune response.
    Cheng J; Zhang Q; Fan S; Zhang A; Liu B; Hong Y; Guo J; Cui D; Song J
    Nanoscale; 2019 Dec; 11(47):22849-22859. PubMed ID: 31755508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity of inorganic nanomaterials in biomedical imaging.
    Li J; Chang X; Chen X; Gu Z; Zhao F; Chai Z; Zhao Y
    Biotechnol Adv; 2014; 32(4):727-43. PubMed ID: 24389087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in Therapeutic Implications of Inorganic Drug Delivery Nano-Platforms for Cancer.
    Naz S; Shamoon M; Wang R; Zhang L; Zhou J; Chen J
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and immunological toxic effects of nanoparticles.
    Pandey RK; Prajapati VK
    Int J Biol Macromol; 2018 Feb; 107(Pt A):1278-1293. PubMed ID: 29017884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Progress in Delivery of Therapeutic and Imaging Agents Utilizing Organic-Inorganic Hybrid Nanoparticles.
    Haque ST; Chowdhury EH
    Curr Drug Deliv; 2018; 15(4):485-496. PubMed ID: 29165073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The toxicity of silica nanoparticles to the immune system.
    Chen L; Liu J; Zhang Y; Zhang G; Kang Y; Chen A; Feng X; Shao L
    Nanomedicine (Lond); 2018 Aug; 13(15):1939-1962. PubMed ID: 30152253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inorganic Nanomaterials as Carriers for Drug Delivery.
    Chen S; Hao X; Liang X; Zhang Q; Zhang C; Zhou G; Shen S; Jia G; Zhang J
    J Biomed Nanotechnol; 2016 Jan; 12(1):1-27. PubMed ID: 27301169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inorganic Nanoparticles for Image-Guided Therapy.
    Yoon HY; Jeon S; You DG; Park JH; Kwon IC; Koo H; Kim K
    Bioconjug Chem; 2017 Jan; 28(1):124-134. PubMed ID: 27788580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing inorganic light-protective skin nanotechnology products.
    Popov AP; Zvyagin AV; Lademann J; Roberts MS; Sanchez W; Priezzhev AV; Myllylä R
    J Biomed Nanotechnol; 2010 Oct; 6(5):432-51. PubMed ID: 21329040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradable Inorganic Nanoparticles for Cancer Theranostics: Insights into the Degradation Behavior.
    Zhou H; Ge J; Miao Q; Zhu R; Wen L; Zeng J; Gao M
    Bioconjug Chem; 2020 Feb; 31(2):315-331. PubMed ID: 31765561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phototriggered Drug Delivery Using Inorganic Nanomaterials.
    Liu Q; Zhan C; Kohane DS
    Bioconjug Chem; 2017 Jan; 28(1):98-104. PubMed ID: 27661196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological effects of iron oxide nanoparticles and iron-based complex drug formulations: Therapeutic benefits, toxicity, mechanistic insights, and translational considerations.
    Shah A; Dobrovolskaia MA
    Nanomedicine; 2018 Apr; 14(3):977-990. PubMed ID: 29409836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.